Stay updated on Temozolomide Plus Nivolumab in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Temozolomide Plus Nivolumab in Colorectal Cancer Clinical Trial page.

Latest updates to the Temozolomide Plus Nivolumab in Colorectal Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added and v3.4.1 removed as part of a site version update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedThe page revision updated from v3.4.0 to v3.4.1; this change does not affect any study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedAdded a Show glossary control and a new 'Last Update Submitted that Met QC Criteria' label to the study record page. The footer now shows 'No FEAR Act Data' and the revision 'v3.4.0', replacing the previous 'No FEAR Act data', older QC label 'Last Update Submitted that met QC Criteria', and 'Revision: v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; this appears to be a minor version update with no substantive content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page footer was updated to Revision: v3.3.3 and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision: v3.3.2 added and v3.2.0 removed. No changes to study details, eligibility criteria, or outcomes.SummaryDifference0.1%

Stay in the know with updates to Temozolomide Plus Nivolumab in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Temozolomide Plus Nivolumab in Colorectal Cancer Clinical Trial page.